Chelated PSMA inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9974869
SERIAL NO

15246483

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds as defined herein are provided which are useful in (1) diagnostic methods for detecting and/or identifying cells presenting PSMA; (2) compositions comprising a compound of the invention together with a pharmaceutically acceptable diluent; and (3) methods for imaging prostate cancer cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CANCER TARGETED TECHNOLOGY LLC14241 NE WOODINVILLE-DUVALL ROAD #143 WOODINVILLE WA 98072

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Berkman, Clifford Pullman, US 8 11
Langton-Webster, Bea Woodinville, US 3 9
Wang, Xiaobing Redmond, US 48 116

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 22, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 22, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00